e-learning
resources
Munich 2014
Monday, 08.09.2014
Animal models in respiratory drug development
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
N-acetylcysteine potentiates surfactant therapy for experimental meconium aspiration syndrome
J. Kopincova, P. Mikolka, D. Mokra, A. Calkovska (Martin, Slovakia)
Source:
International Congress 2014 – Animal models in respiratory drug development
Session:
Animal models in respiratory drug development
Session type:
Poster Discussion
Number:
1798
Disease area:
Airway diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Kopincova, P. Mikolka, D. Mokra, A. Calkovska (Martin, Slovakia). N-acetylcysteine potentiates surfactant therapy for experimental meconium aspiration syndrome. Eur Respir J 2014; 44: Suppl. 58, 1798
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Therapy of inflammation in light of respiratory and inflammatory markers in experimental model of meconium aspiration syndrome
Source: Annual Congress 2013 –Neonatal and paediatric intensive care
Year: 2013
Effects of nebulized heparin in a rat-model of endotoxemia-induced lung injury
Source: International Congress 2014 – Critical illness and therapeutic interventions
Year: 2014
Anti-inflammatory effects of targeted lung denervation in patients with COPD
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: An experimental study
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
AZD5069: Pharmacological profile of a CXCR2 antagonist in development for the treatment of respiratory disorders
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Effects of nebulized heparin on pulmonary inflammation in a rat model of acute lung injury
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015
Comparison of three modalities of corticosteroids administration in chronic rhinosinusitis
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
The potential efficacy of noninvasive ventilation with administration of a neutrophil elastase inhibitor for acute respiratory distress syndrome
Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning
Year: 2014
Oral inhalation of AP301 peptide activates pulmonary oedema clearance: Initial results from a phase IIa clinical trial in mechanically ventilated ICU patients
Source: International Congress 2014 – Critical illness and therapeutic interventions
Year: 2014
Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015
Preventive and therapeutic treatment with a7 nicotinic receptor agonist reduced lung inflammation and collagen deposition in mice with acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Effect of antithrombin in an in vitro model of acute respiratory distress syndrome
Source: International Congress 2016 – Sepsis and ARDS: looking forward
Year: 2016
Effects of VAChT reduction on the time course of lung inflammation in mice with acute lung injury
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014
Long-acting anticholinergics in the treatment of severe asthma with irreversible airway obstruction
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Lung recruitment maneuver with and without nebulized albuterol for acute lung injury
Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning
Year: 2014
Aerobic exercise decreases pulmonary and extrapulmonary LPS-induced ARDS through IL-10 and TLR-4 modulation
Source: International Congress 2014 – Immunology of respiratory infections
Year: 2014
The prevention of postoperative respiratory complications in lung surgery
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014
Neurogenic pulmonary edema: Effect of corticosteroids
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015
Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept